Safety and Tolerability of NIM-1324, an Oral, Once-daily LANCL2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study in Normal Healthy Volunteers

被引：0

作者：

Leber, Andrew ^{[1
]}

Hontecillas, Raquel ^{[1
]}

Juni, Nuria Tubau ^{[1
]}

Bassaganya-Riera, Josep ^{[1
]}

机构：

[1] NIMML Inst, Blacksburg, VA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2337

引用

页码：4631 / 4632

页数：2

共 50 条

[31] Double-blind, placebo-controlled study of once-daily venlafaxine (XR) and fluoxetine in depressed outpatients [J].

Rudolph, R ;

Aguiar, L ;

Entsuah, R ;

Derivan, A .

PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) :578-578

[32] Safety and tolerability of Ganoderma lucidum in healthy subjects:: A double-blind randomized placebo-controlled trial [J].

Wicks, Sheila M. ;

Tong, Robin ;

Wang, Chong-Zhi ;

O'Connor, Michael ;

Karrison, Theodore ;

Li, Shang ;

Moss, Jonathan ;

Yuan, Chun-Su .

AMERICAN JOURNAL OF CHINESE MEDICINE, 2007, 35 (03) :407-414

[33] Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study [J].

Irie, S. ;

Matsumura, Y. ;

Zdravkovic, M. ;

Jacobsen, L. V. ;

Kageyama, S. .

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (06) :273-279

[34] Tolerability of indacaterol, a novel once-daily β2-agonist, in patients with asthma:: a randomized, placebo-controlled, 28-day safety study [J].

Yang, William H. ;

Martinot, Jean Benoit ;

Pohunek, Petr ;

Beier, Jutta ;

Magula, Daniel ;

Cameron, Ray ;

Owen, Roger ;

Higgins, Mark .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 99 (06) :555-561

[35] Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study [J].

Ring, J ;

Hein, R ;

Gauger, A ;

Bronsky, E ;

Miller, B .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (01) :72-76

[36] Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: A double-blind, placebo-controlled study [J].

Adachi, Mitsuru ;

Ishihara, Kyosuke ;

Inoue, Hiroshi ;

Kudo, Koichiro ;

Takahashi, Kiyoshi ;

Morita, Yutaka ;

Masuda, Ken-Ichi ;

Takada, Yoshinori ;

Kato, Ryuichi ;

Miyamoto, Terumasa .

RESPIROLOGY, 2007, 12 (04) :566-572

[37] Safety and tolerability of medicinal parasite ova (Trichuris suis) in healthy Japanese volunteers: A randomized, double-blind, placebo-controlled trial [J].

Hoshina, Tokio ;

Sakurai, Tatsuya ;

Ichimura, Hidetoshi ;

Ishiwata, Kenji ;

En, Shitan ;

Yamada, Takahiro ;

Kwangyole, Lee ;

Shimizu, Akihiro ;

Hase, Koji ;

Kanuka, Hirotaka .

PARASITOLOGY INTERNATIONAL, 2021, 85

[38] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

Hanauer, Stephen ;

O'Reilly, Terry ;

Lester, Robert ;

Slatkin, Neal ;

Lee, Jimin ;

Franklin, Howard ;

Bulawski, Angela ;

Israel, Robert .

GASTROENTEROLOGY, 2021, 160 (03) :S1-S2

[39] Safety and Tolerability of Once-Daily Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Studies [J].

Kremens, Daniel ;

Poewe, Werner ;

Rascol, Olivier ;

Olson, Kurt ;

Farahmand, Khodayar ;

Siegert, Scott ;

McMicken, Carolyn ;

Rocha, Jose-Francisco ;

Soares-da-Silva, Patricio ;

Liang, Grace S. .

ANNALS OF NEUROLOGY, 2019, 86 :S84-S84

[40] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].